1.. INTRODUCTION {#S1}
================

*Actinobacillus pleuropneumoniae*, a member of the *Pasteurellaceae*, is an important swine pathogen responsible for economic losses in the swine industry. To date, 15 serotypes of *A*. *pleuropneumoniae* have been described based on capsular antigens \[[@R3], [@R10]\]. The virulence of the bacteria is mediated by the coordinated action of several virulence factors, namely the capsule, lipopolysaccharides (LPS), Apx toxins and outer membrane proteins involved in iron uptake \[[@R4], [@R11], [@R14], [@R18], [@R19], [@R28], [@R29]\].

It is widely accepted that the majority of bacteria in virtually all ecosystems (natural, engineered and pathogenic ecosystems) grow in matrix-enclosed biofilms \[[@R7]\]. The matrix provides biofilm cells with a protected microenvironment containing nutrients, secreted enzymes and DNA. The matrix also contributes to the increased resistance to antibiotics and host defenses exhibited by biofilm cells \[[@R15]\]. All members of the *Pasteurellaceae* are inhabitants of mucosal surfaces of mammals and therefore formation of a biofilm may be crucial to their persistence in vivo. However, biofilms have only been investigated in a few species of the *Pasteurellaceae* family \[[@R16]\]. In *A*. *pleuropneumoniae*, the formation of biofilms on polystyrene microtiter plate is dependent on the production of poly-N-acetylglucosamine (PGA) a linear polymer of N-acetylglucosamine residues in β(1,6) linkage \[[@R17], [@R20]\]. The production of PGA is encoded by the genes *pgaABCD* \[[@R20]\]. A novel insertion element, ISApl1, was recently identified in an A/T rich region of the *pgaC* gene of the biofilm-negative *A*. *pleuropneumoniae* strain HB04 \[[@R25]\]. PGA is a substrate for dispersin B (DspB), a biofilm-releasing glycosyl hydrolase produced by *Aggregatibacter* (*Actinobacillus*) *actinomycetemcomitans* and *A*. *pleuropneumoniae* \[[@R20], [@R22]\]. It has also been reported that only 2 of the 15 *A*. *pleuropneumoniae* reference strains, representing serotypes 5b and 11, were able to form a biofilm in vitro and that the transition from a biofilm-positive to biofilm-negative phenotype was irreversible \[[@R21]\]. However, Li et al. \[[@R24]\] recently observed slight biomass of biofilm when the *A*. *pleuropneumoniae* serotype 1 reference strain S4074 was grown in serum-free TSB but not in serum-containing TSB. In addition, an enhanced biofilm formation was observed in *luxS* \[[@R24]\] and *hns* \[[@R8]\] mutants of *A*. *pleuropneumoniae* strain S4074.

The aims of the present study were: (i) to re-evaluate biofilm formation by *A*. *pleuropneumoniae* reference strain S4074 (serotype 1) under different growth conditions using a standard microtiter plate and crystal violet staining protocol; (ii) to evaluate the ability of 16 reference strains and 37 fresh field isolates to form biofilm in the growth condition shown to allow the best biofilm formation and (iii) to determine the transcriptomic profile of *A*. *pleuropneumoniae* strain S4074 when grown in that culture condition.

2.. MATERIALS AND METHODS {#S2}
=========================

2.1.. Bacterial strains and growth conditions {#S3}
---------------------------------------------

Bacterial strains used in the present study are listed in [Table I](#T1){ref-type="table"}. Bacteria were grown on brain heart infusion agar plates (BHI; Difco Laboratories, Detroit, MI, USA) supplemented with 15 μg/mL nicotinamide adenine dinucleotide (NAD). A colony was transferred into 5 mL of Luria-Bertani broth (LB; Difco), tryptic soy broth (TSB; Difco), Mueller Hinton broth (MH; Difco) or BHI (BHI-A; Difco or BHI-B; Oxoid Ltd, Basingstoke, Hampshire, UK) with 5 μg/mL NAD and incubated at 37 °C overnight with agitation. This culture was used for the biofilm assays.Table I.*A*. *pleuropneumoniae* strains used in the present study.StrainsRelevant traitsSource**Reference strains**S4074Serotype 1K.R. Mittal[1](#TFN1){ref-type="fn"}4226Serotype 2K.R. Mittal[1](#TFN1){ref-type="fn"}1421Serotype 3K.R. Mittal[1](#TFN1){ref-type="fn"}1462Serotype 4K.R. Mittal[1](#TFN1){ref-type="fn"}K17Serotype 5aK.R. Mittal[1](#TFN1){ref-type="fn"}L20Serotype 5bK.R. Mittal[1](#TFN1){ref-type="fn"}FEMOSerotype 6K.R. Mittal[1](#TFN1){ref-type="fn"}WF.83Serotype 7K.R. Mittal[1](#TFN1){ref-type="fn"}405Serotype 8K.R. Mittal[1](#TFN1){ref-type="fn"}13261Serotype 9K.R. Mittal[1](#TFN1){ref-type="fn"}13039Serotype 10K.R. Mittal[1](#TFN1){ref-type="fn"}56153Serotype 11K.R. Mittal[1](#TFN1){ref-type="fn"}832985Serotype 12K.R. Mittal[1](#TFN1){ref-type="fn"}N273[4](#TFN4){ref-type="fn"}Serotype 13M. Gottschalk[1](#TFN1){ref-type="fn"}3906[4](#TFN4){ref-type="fn"}Serotype 14M. Gottschalk[1](#TFN1){ref-type="fn"}HS143Serotype 15M. Gottschalk[1](#TFN1){ref-type="fn"}**Field strains**05-7430, 05-7431Serotype 1M. Ngeleka[2](#TFN2){ref-type="fn"}111A, 719, 2398, 2521Serotype 1D. Slavic[3](#TFN3){ref-type="fn"}05-4817, 05-C996, 06-996Serotype 5aS. Messier[1](#TFN1){ref-type="fn"}04-37943, 04-3128, 05-508Serotype 5aM. Ngeleka[2](#TFN2){ref-type="fn"}05-6501, 06-4091Serotype 5bS. Messier[1](#TFN1){ref-type="fn"}03-14796, 03-22382, 03-22383, 05-4832Serotype 5bM. Ngeleka[2](#TFN2){ref-type="fn"}366A, 400, 564D, 888Serotype 5bD. Slavic[3](#TFN3){ref-type="fn"}05-3695, 06-3008, 06-3060, 06-4108Serotype 7S. Messier[1](#TFN1){ref-type="fn"}04-37257, 05-14401Serotype 7M. Ngeleka[2](#TFN2){ref-type="fn"}881, 986, 1951, 4648Serotype 7D. Slavic[3](#TFN3){ref-type="fn"}05-13146, 05-14657, 05-20080, 05-20081, 05-2983Serotype 15M. Ngeleka[2](#TFN2){ref-type="fn"}[^1][^2][^3][^4]

2.2.. Biofilm assay in microtiter plates {#S4}
----------------------------------------

The microtiter plate biofilm assay is a static assay particularly useful for examining early events in biofilm formation \[[@R27]\]. The wells of a sterile 96-well microtiter plate (Costar^®^ 3599, Corning, NY, USA) were filled in triplicate with a dilution (1/100) of an overnight bacterial culture. Following an incubation of 6 or 24 h at 37 °C, the wells were washed by immersion in water and excess water was removed by inverting plates onto a paper towel. The wells were then filled with 100 μL of crystal violet (0.1%) and the plate was incubated for 2 min at room temperature. After removal of the crystal violet solution, the plate was washed and dried in a 37 °C incubator for 30 min and 100 μL of ethanol (70%) were added to the wells. Absorbance was measured at 590 nm using a spectrophotometer (Powerwave, BioTek Instruments, Winooski, VT, USA).

2.3.. Scanning laser confocal microscopy {#S5}
----------------------------------------

The same biofilm assay protocol was used as described previously. After the 6 or 24 h incubation, the wells were filled with 100 μL of Wheat Germ Agglutinin (WGA)--Oregon Green 488 (Molecular Probes, Eugene, OR, USA) diluted 1/100 in PBS and the plate was incubated for 30 min at room temperature in the dark. The plate was then washed with water and filled with PBS. The plate was observed with a confocal microscope (Olympus FV1000 IX81). WGA was excited at 488 nm and detected using 520 nm filters. The images were processed using Fluoview software (Olympus).

2.4.. Transcriptomic microarray experiments {#S6}
-------------------------------------------

### 2.4.1.. RNA extractions {#S7}

For the microarray experiments, BHI-A or BHI-B broths were inoculated with 500 μL of an overnight culture of *A*. *pleuropneumoniae* serotype 1 strain S4074 and grown at 37 °C in an orbital shaker until an optical density of 0.6 was reached. Ice-cold RNA degradation stop solution (95% ethanol, 5% buffer-saturated phenol), shown to effectively prevent RNA degradation and therefore preserve the integrity of the transcriptome \[[@R2]\], was added to the bacterial culture at a ratio of 1:10 (vol/vol). The sample was mixed by inversion, incubated on ice for 5 min, and then spun at 5 000 *g* for 10 min to pellet the cells. Bacterial RNA isolation was then carried out using the QIAGEN RNeasy MiniKit (QIAGEN, Mississauga, ON, Canada), as prescribed by the manufacturer. During the extraction, samples were subjected to an on-column DNase treatment, as suggested by the manufacturer and then treated with Turbo DNase (Ambion, Austin, TX, USA) to ensure that all DNA contaminants were eliminated. The RNA concentration, quality and integrity were assessed spectrophotometrically and on gel.

### 2.4.2.. Microarray construction and design {#S8}

For the construction of AppChip2, 2033 ORFs from the complete genome sequence of *A*. *pleuropneumoniae* serotype 5b strain L20, representing more than 95% of all ORFs with a length greater than 160 nt, were amplified and spotted in duplicate on the chip. Spotted sheared genomic DNA from *A*. *pleuropneumoniae* L20 and porcine DNA are used as controls (GEO: GPL6658). Additional information concerning chip production is described by Gouré et al. \[[@R13]\].

### 2.4.3.. Microarray hybridizations {#S9}

cDNA synthesis and microarray hybridizations were performed as described \[[@R6]\]. Briefly, equal amounts (15 μg) of test RNA and control RNA were used to set up a standard reverse transcription reaction using random octamers (BioCorp, Montreal, QC, Canada), SuperScript II (Invitrogen, Carlsbad, CA, USA) and aminoallyl-dUTP (Sigma, St. Louis, MO, USA), and the resulting cDNA was indirectly labelled using a monofunctional NHS-ester Cy3 or Cy5 dye (Amersham, Buckinghamshire, UK). The labelling efficiency was assessed spectrophotometrically. Labelled samples were then combined and added to the AppChip2 for overnight hybridization. Five hybridizations were performed for the serotype 1 strain S4074 BHI-A versus BHI-B experiments. All slides were scanned using a Perkin-Elmer ScanArray Express scanner.

### 2.4.4.. Microarray analysis and bioinformatics {#S10}

Microarray data analysis was conducted with the TM4 Suite of software from the J. Craig Venture Institute \[[@R30]\] as described by Deslandes et al. \[[@R9]\]. Briefly, raw data was first generated using SpotFinder v.3.1.1. Locally weighted linear regression (lowess) was then performed in the Microarray Data Analysis System (MIDAS) in order to normalize the data. The Significance Analysis of Microarray (SAM) algorithm \[[@R33]\], which is implemented in TIGR Microarray Expression Viewer (TMEV), was used to generate a list of differentially expressed genes. During SAM analysis, a false discovery rate (FDR) of 0% was estimated for the serotype 1 strain S4074 BHI-A versus BHI-B experiments.

2.5.. Effects of DspB and zinc on biofilm formation {#S11}
---------------------------------------------------

Biofilms were grown for 6 or 24 h in BHI-B as described above. The wells were washed with water and then filled with 100 μL of PBS containing 0.2, 2.0 or 20 μg/mL of DspB (Kane Biotech Inc, Winnipeg, MB, Canada) as described by Izano et al. \[[@R17]\]. After incubation at 37 °C for 5 min, the wells were rinsed with water and stained with crystal violet. To monitor the effect of zinc on biofilm formation, bacteria were grown for 6 or 24 h in BHI-B supplemented with 50--250 μg/mL of ZnCl~2~.

2.6.. Statistical analysis {#S12}
--------------------------

The statistical significance (*p* value) of differences in biofilm phenotypes (mean optical density values) was determined by a paired, one-tailed *t*-test using GraphPad Prism version 4.0 (GraphPad Software, San Diego, CA, USA).

3.. RESULTS {#S13}
===========

3.1.. Biofilm formation and growth conditions {#S14}
---------------------------------------------

The ability of the *A*. *pleuropneumoniae* serotype 1 reference strain S4074 to form biofilms was evaluated using different growth media ([Fig. 1](#F1){ref-type="fig"}). No biofilm was present in the wells containing bacterial cells grown in LB broth while only a slight biofilm was observed in wells containing cells grown in TSB, MH or BHI-A broths after 24 h of incubation. However a pronounced biofilm (*p* \< 0.01) was formed when strain S4074 was grown in BHI-B broth. This was not due to an increased growth in BHI-B compared to BHI-A as similar growth curves were observed in both media.Figure 1.Biofilm formation by *A*. *pleuropneumoniae* serotype 1 reference strain S4074 grown in different culture media using the crystal violet staining protocol described in Materials and methods. LB: Luria-Bertani; TSB: tryptic soy broth; M-H: Mueller Hinton; BHI: brain heart infusion.

We then evaluated biofilm formation by all the reference strains of *A*. *pleuropneumoniae* after growth for 6 or 24 h in BHI-B. Similarly to what was observed with the serotype 1, we found that growth in BHI-B, but not BHI-A, allows biofilm formation in reference strains representing serotypes 4, 5a and 14. In addition to the already reported biofilm formation in serotypes 5b and 11, we also observed biofilms for serotype 3 and 12 reference strains. Moreover, biofilm formation (OD~590nm~ \> 0.1) was observed in 20 (54%) of the 37 fresh field isolates of serotypes 1, 5, 7 and 15 that were tested ([Fig. 2](#F2){ref-type="fig"}). In general, serotypes 5a, 5b and 7 field isolates tend to form more biofilms (mean OD of 1.15, 1.47 and 1.47 after 24 h) than isolates from serotypes 1 and 15 (mean OD of 0.36 and 0.80 after 24 h).Figure 2.Thirty-seven independent fresh field isolates of *A*. *pleuropneumoniae* (representing serotypes 1, 5, 7 and 15) were tested for their ability to form biofilms when grown for 6 h (A) and 24 h (B) in BHI-B using the microtiter plate assay.

When *A*. *pleuropneumoniae* strain S4074 grown in BHI-A (no or slight biofilm) was transferred to BHI-B we observed the formation of a pronounced biofilm (*p* \< 0.05). When these cells were then transferred back to BHI-A, the phenotype returned to a slight biofilm (*p* \< 0.05). This was also observed with field isolates representing different serotypes (data not shown).

3.2.. Scanning laser confocal microscopy {#S15}
----------------------------------------

We observed that for many reference strains, including strain S4074, and field isolates, pronounced biofilms were present after a short incubation period of only 6 h ([Fig. 2](#F2){ref-type="fig"}). The biofilm was visualized by confocal laser scanning microscopy using a fluorescent probe (WGA-Oregon Green) specific to the PGA matrix polysaccharide ([Fig. 3](#F3){ref-type="fig"}). It is evident from these micrographs that *A*. *pleuropneumoniae* strain S4074 does not form biofilm when grown in BHI-A while a thick PGA matrix is formed by *A*. *pleuropneumoniae* serotype 5b strain L20 grown in the same condition. However, both strains showed a pronounced biofilm when grown in BHI-B. In the case of strain S4074, the biofilm is even more important after 6 h than 24 h of incubation ([Fig. 3](#F3){ref-type="fig"}). Because scanning laser confocal microscopy allows optical sectioning of the biofilm either in the horizontal or the vertical dimension it is possible to evaluate the thickness of the biofilm. We evaluated the thickness of *A*. *pleuropneumoniae* strain S4074 biofilm to be of \~ 25 μm after growth in BHI-B for 6 h ([Fig. 3C](#F3){ref-type="fig"}) and even greater (\~ 65 μm) for *A*. *pleuropneumoniae* strain L20.Figure 3.Confocal scanning laser microscopic images of *A*. *pleuropneumoniae* serotype 1 strain S4074 (A and C) and serotype 5b strain L20 (B) biofilms stained with WGA-Oregon Green 488. (C) Stack of sections through the X--Z plane of a biofilm formed after 6 h in BHI-B. Bars = 50 μm.

3.3.. Transcriptomic profiling under different growth conditions {#S16}
----------------------------------------------------------------

To assess the transcriptional response of *A*. *pleuropneumoniae* S4074 after growth in BHI-B compared to BHI-A, transcript profiling experiments using DNA microarrays were performed. Overall, 232 genes were significantly differentially expressed during growth in BHI-B; 152 being up-regulated and 80 being down-regulated ([Tab. II](#T2){ref-type="table"}). The genes that showed the highest level of up-regulation after growth in BHI-B belonged to the "amino acid biosynthesis", "energy metabolism", "transport and binding proteins", "cell envelope" and "hypothetical/unknown/unclassified" functional classes ([Fig. 4](#F4){ref-type="fig"}). Genes such as *tadC* and *tadD* (tight adherence proteins C and D), genes with homology to autotransporter adhesins (APL_0443 and APL_0104) as well as genes *pgaABC* involved in PGA biosynthesis were up-regulated after growth in BHI-B. A cluster of genes involved in dipeptide transport (*dppABCDF*) and genes involved in the synthesis of an urease (*ureAEFG*) were also up-regulated. Down-regulated genes after growth in BHI-B mostly belonged to the "transport and binding proteins", "cell envelope", "protein synthesis" and "hypothetical/unknown/unclassified" functional classes. Most notably, *cys* genes involved in sulphate transport systems were down-regulated, as well as a gene (APL_1096) sharing 59% identity with the DspB gene of *A*. *actinomycetemcomitans*.Figure 4.Functional classification of the differentially expressed genes during growth of *A*. *pleuropneumoniae* S4074 in BHI-B according to TIGRFAM. AAB: amino acids biosynthesis; BCPC: biosynthesis of cofactors, prosthetic groups and carriers; CE: cell envelope; CP: cellular processes; CIM: central intermediary metabolism; DNA: DNA metabolism; EM: energy metabolism; FAPM: fatty acid and phospholipid metabolism; HUU: hypothetical proteins/unclassified/unknown; MEEF: mobile and extrachromosomal element functions; PF: protein fate; PS: protein synthesis; PPNN: purines, pyrimidines, nucleosides and nucleotides; RF: regulatory functions; TR: transcription and TBP: transport and binding proteins. Table II.*A*. *pleuropneumoniae* strain S4074 genes that are up- or down-regulated after growth in BHI-B compared to growth in BHI-A.Locus tagGeneDescriptionFold change*Amino acid biosynthesis*APL_0728*ilvH*Acetolactate synthase small subunit5.707APL_0662*aspC*Putative aspartate aminotransferase5.324APL_0427*gdhA*NADP-specific glutamate dehydrogenase4.943APL_0727*ilvI*Acetolactate synthase large subunit4.204APL_0099*ilvG*Acetolactate synthase isozyme II large subunit (AHAS-II)3.915APL_1499*thrC*Threonine synthase3.198APL_0097*ilvD*Dihydroxy-acid dehydratase3.142APL_0393*leuA*2-isopropylmalate synthase3.000APL_0098*ilvM*Acetolactate synthase isozyme II small subunit (AHAS-II)2.934APL_2027*hisF*Imidazole glycerol phosphate synthase subunit hisF2.833APL_0702*serC*Phosphoserine aminotransferase2.788APL_0432*leuB*3-isopropylmalate dehydrogenase2.643APL_0899*dapA*Dihydrodipicolinate synthase2.401APL_0211*glyA*Glycine/serine hydroxymethyltransferase2.398APL_0133*cysB*HTH-type transcriptional regulator CysB2.340APL_1853*ilvC*Ketol-acid reductoisomerase2.313APL_0072*ilvE*Branched-chain-amino-acid aminotransferase2.001APL_0859*trpCF*Tryptophan biosynthesis protein trpCF1.883APL_2025*hisH*Imidazole glycerol phosphate synthase subunit hisH1.777APL_2026*hisA*Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase1.739APL_1198*APL_1198*Putative NAD(P)H nitroreductase1.708APL_0139*leuC*3-isopropylmalate dehydratase large subunit 21.605APL_1230*serB*Phosphoserine phosphatase1.438APL_0620*aroG*Phospho-2-dehydro-3-deoxyheptonate aldolase1.428APL_1873*dapE*Succinyl-diaminopimelate desuccinylase1.380*Biosynthesis of cofactors, prosthetic groups, and carriers*APL_0207*Dxs*1-deoxy-D-xylulose-5-phosphate synthase (DXPS)−1.555APL_1461*menA*1,4-dihydroxy-2-naphthoateoctaprenyltransferase−1.631APL_0382*ribD*Riboflavin biosynthesis protein−1.726APL_1408*gshA*Glutathione biosynthesis bifunctional protein GshAB−1.789*Cell envelope*APL_1494*ftpA*Fine tangled pili major subunit5.705APL_1921*pgaA*Biofilm PGA synthesis protein PgaA precursor5.308APL_0460*plpD*Lipoprotein Plp43.801APL_1923*pgaC*Biofilm PGA synthesis N-glycosyltransferase PgaC3.591APL_1922*pgaB*Biofilm PGA synthesis lipoprotein PgaB precursor3.093APL_0006*ompP2A*Outer membrane protein P22.515APL_0550*tadC*Tight adherence protein C1.985APL_0442*sanA*SanA protein1.776APL_0549*tadD*Tight adherence protein D1.749APL_0332*hlpB*Lipoprotein HlpB1.627APL_1364*gmhA*Putative phosphoheptose isomerase1.386APL_0873*rlpB*Putative rare lipoprotein B−1.391APL_1028*APL_1028*Possible lipooligosaccharide N-acetylglucosamine glycosyltransferase−1.445APL_0747*mepA*Penicillin-insensitive murein endopeptidase precursor−1.446APL_0436*mreC*Rod shape-determining protein MreC−1.585APL_1086*ompW*Outer membrane protein W precursor−1.606APL_1029*APL_1029*Hypothetical protein−1.650APL_1424*oxaA*Inner membrane protein OxaA−1.772APL_0933*ompP1*Putative outer membrane protein precursor−2.808*Cellular processes*APL_1489*Tpx*Putative thiol peroxidase2.252APL_0988*hktE*Catalase−1.461APL_0669*APL_0669*Putative iron dependent peroxidase−1.483APL_1442*apxID*RTX-I toxin secretion component−1.506APL_1346*ftsY*Cell division protein FtsY-like protein−1.530*Central intermediary metabolism*APL_1615*Gst*Putative glutathione S-transferase3.269APL_1614*ureE*Urease accessory protein UreE2.601APL_1613*ureF*Urease accessory protein UreF2.478APL_1612*ureG*Urease accessory protein UreG2.165APL_1618*ureA*Urease gamma subunit UreA1.653*DNA metabolism*APL_1931*tagI*3-methyladenine-DNA glycosidase−1.500APL_1474*dnaG*DNA primase−1.551APL_1282*dnaQ*DNA polymerase III subunit−1.579APL_1255*parE*DNA topoisomerase IV subunit−1.630APL_1505*holC*DNA polymerase III subunit−1.663*Energy metabolism*APL_1197*APL_1197*3-hydroxyacid dehydrogenase3.100APL_0841*pntB*NAD(P) transhydrogenase subunit beta2.726APL_1908*xylA*Xylose isomerase2.243APL_0894*fdxH*Formate dehydrogenase, iron-sulfur subunit2.161APL_1425*napC*Cytochrome c-type protein NapC2.159APL_1799*torC*Pentahemic c-type cytochrome2.156APL_0892*fdxG*Formate dehydrogenase, nitrate-inducible, major subunit2.116APL_1798*torA*Trimethylamine-N-oxide reductase precursor1.977APL_0381*glpC*Anaerobic glycerol-3-phosphate dehydrogenase subunit C1.919APL_0842*pntA*NAD(P) transhydrogenase subunit alpha1.903APL_0895*fdnI*Formate dehydrogenase, cytochrome b556 subunit1.816APL_1208*adhC*Putative alcohol dehydrogenase class 31.801APL_0971*APL_0971*Putative acyl CoA thioester hydrolase1.796APL_0652*manB*Phosphomannomutase1.677APL_0483*APL_0483*Predicted nitroreductase1.668APL_0142*glxK*Glycerate kinase1.564APL_0452*sucC*Succinyl-CoA synthetase beta chain1.515APL_0461*APL_0461*Predicted hydrolases of the HAD superfamily1.456APL_0687*Dld*D-lactate dehydrogenase1.439APL_1510*gpsA*Glycerol-3-phosphate dehydrogenase (NAD(P)+)1.414APL_1427*napH*Ferredoxin-type protein NapH-like protein1.360APL_0789*APL_0789*Dioxygenase1.253APL_0983*tktA*Transketolase 21.233APL_1036*pflB*Formate acetyltransferase−1.653APL_1498*mgsA*Methylglyoxal synthase−1.790APL_1840*ubiC*4-hydroxybenzoate synthetase (chorismate lyase)−1.952APL_0857*sdaA*L-serine dehydratase−3.016*Fatty acid and phospholipid metabolism*APL_1407*Psd*Phosphatidylserine decarboxylase−1.419APL_1384*fabH*3-oxoacyl-\[acyl-carrier-protein\] synthase 3−1.826APL_1385*plsX*Fatty acid/phospholipid synthesis protein PlsX−2.706*Mobile and extrachromosomal element functions*APL_1056*APL_1056*Transposase1.560APL_0985*APL_0985*Transposase1.271Protein fateAPL_0871*pepE*Peptidase E2.551APL_1101*pepA*Putative cytosol aminopeptidase1.913APL_0254*pepD*Aminoacyl-histidine dipeptidase1.903APL_1883*ptrA*Protease 3 precursor1.680APL_0928*hscB*Co-chaperone protein HscB-like protein1.377APL_1068*secF*Protein-export membrane protein SecF−1.496APL_0321*dsbB*Disulfide bond formation protein B−1.557APL_1035*pflA*Pyruvate formate-lyase 1-activating enzyme−1.774*Protein synthesis*APL_1821*rpmE*50S ribosomal protein L312.211APL_0484*rimK*Ribosomal protein S6 modification protein1.533APL_1781*rpsM*30S ribosomal protein S13−1.401APL_0205*APL_0205*Predicted rRNA methyltransferase−1.538APL_0399*ksgA*Dimethyladenosine transferase−1.578APL_0679*glnS*Glutaminyl-tRNA synthetase−1.584APL_0641*truB*tRNA pseudouridine synthase B−1.742APL_1383*trmB*tRNA (guanine-N(7)-)-methyltransferase−1.756APL_0574*APL_0574*tRNA-specific adenosine deaminase−1.778APL_0723*Tgt*Queuine tRNA-ribosyltransferase−1.937*Purines, pyrimidines, nucleosides, and nucleotides*APL_0958*purH*Bifunctional purine biosynthesis protein PurH1.856APL_0593*guaB*Inosine-5′-monophosphate dehydrogenase1.485APL_1343*Cdd*Cytidine deaminase1.278APL_1014*deoD*Purine nucleoside phosphorylase DeoD-like protein−1.430APL_0351*Ndk*Nucleoside diphosphate kinase−1.531APL_1839*Udp*Uridine phosphorylase−1.617APL_1075*purA*Adenylosuccinate synthetase−1.762*Regulatory functions*APL_0059*narP*Nitrate/nitrite response regulator protein2.552APL_0823*glpR*Glycerol-3-phosphate regulon repressor1.908APL_1295*argR*Arginine repressor1.896APL_0126*APL_0126*HIT-like protein1.580APL_0395*rseA*Putative sigma-E factor negative regulatory protein1.524APL_1668*rbsR*Ribose operon repressor1.302APL_1270*sprT*Putative SprT-like protein−1.483APL_1233*malT*HTH-type transcriptional regulator MalT−1.484APL_1540*tldD*TldD-like protein−1.578TranscriptionAPL_0560*rhlB*ATP-dependent RNA helicase RhlB1.409APL_0423*rnhA*Ribonuclease HI1.345APL_0201*nusB*Transcription antitermination protein NusB−1.457*Transport and binding proteins*APL_0967*gltS*Sodium/glutamate symport carrier protein4.155APL_0377*glpT*Glycerol-3-phosphate transporter3.247APL_0064*dppA*Periplasmic dipeptide transport protein3.168APL_0869*abgB*Aminobenzoyl-glutamate utilization-like protein3.004APL_1857*merP*Copper chaperone MerP2.911APL_0068*dppF*Dipeptide transport ATP-binding protein DppF2.860APL_1665*gntP_1*Gluconate permease2.723APL_0066*dppC*Dipeptide transport system permease protein DppC2.640APL_1440*znuA*High-affinity zinc uptake system protein ZnuA precursor2.600APL_0065*dppB*Dipeptide transport system permease protein DppB2.229APL_0067*dppD*Dipeptide transport ATP-binding protein DppD2.036APL_1448*afuC*Ferric ABC transporter ATP-binding protein1.855APL_1319*ptsB*PTS system sucrose-specific EIIBC component1.744APL_1320*thiQ*Thiamine transport ATP-binding protein ThiQ1.569APL_1622*cbiM*Predicted ABC transport permease protein CbiM1.433APL_1620*cbiO*Predicted ABC transport ATP-binding protein CbiO1.417APL_1173*pnuC*Nicotinamide mononucleotide transporter1.408APL_0749*APL_0749*Potassium efflux system KefA−1.436APL_1212*tehA*Tellurite resistance protein TehA−1.543APL_0716*APL_0716*Iron(III) ABC transporter, permease protein−1.547APL_1253*APL_1253*Putative sodium/sulphate transporter−1.598APL_1846*cysT*Sulfate transport system permease protein cysT−1.684APL_0191*APL_0191*Predicted Na+-dependent transporter of the SNF family−1.751APL_1083*arcD*Putative arginine/ornithine antiporter−1.786APL_2016*fhuA*Ferrichrome-iron receptor FhuA−2.031APL_1847*cysW*Sulfate transport system permease protein cysW−2.195APL_1844*cysN*Sulphate adenylate transferase subunit 1−2.375APL_1848*cysA*Sulfate/thiosulfate import ATP-binding protein cysA−2.401APL_1843*cysJ*Sulfite reductase \[NADPH\] flavoprotein alpha-component−2.757APL_1127*APL_1127*Predicted Na+/alanine symporter−3.402*Hypothetical/unknown/unclassified*APL_1100*APL_1100*Hypothetical protein3.395APL_0920*APL_0920*Hypothetical protein2.835APL_1882*APL_1882*Hypothetical protein2.776APL_1856*APL_1856*Hypothetical protein2.775APL_1855*APL_1855*Hypothetical protein2.763APL_0443*APL_0443*Autotransporter adhesin2.762APL_1252*APL_1252*Hypothetical protein2.739APL_0134*APL_0134*Hypothetical protein2.681APL_0836*APL_0836*Putative transcriptional regulator2.661APL_1588*APL_1588*Predicted TRAP transporter solute receptor2.464APL_1491*APL_1491*Hypothetical protein2.282APL_0104*APL_0104*Autotransporter adhesin2.231APL_1069*ftnA*Ferritin-like protein 12.194APL_1059*APL_1059*Hypothetical transposase-like protein2.172APL_1690*APL_1690*Inner membrane protein2.168APL_0245*APL_0245*Transferrin binding protein-like solute binding protein2.097APL_1191*namA*NADPH dehydrogenase2.078APL_1948*APL_1948*Hypothetical protein2.061APL_0870*APL_0870*Putative C4-dicarboxylate transporter2.034APL_0643*APL_0643*Hypothetical protein2.029APL_1743*APL_1743*Ser/Thr protein phosphatase family protein1.999APL_0426*APL_0426*Hypothetical protein1.994APL_1791*APL_1791*Putative periplasmic iron/siderophore binding protein1.944APL_0970*APL_0970*Hypothetical protein1.908APL_1070*ftnB*Ferritin-like protein 21.907APL_1894*APL_1894*Hypothetical protein1.907APL_1374*APL_1374*Hypothetical protein1.803APL_1206*APL_1206*Plasmid stability-like protein1.794APL_1881*APL_1881*Hypothetical protein1.792APL_0038*APL_0038*Hypothetical protein1.730APL_1355*APL_1355*Hypothetical protein1.716APL_0471*APL_0471*Hypothetical protein1.707APL_1438*APL_1438*Hypothetical protein1.689APL_1437*APL_1437*Hypothetical protein1.643APL_1423*APL_1423*Hypothetical protein1.612APL_0125*APL_0125*Hypothetical protein1.608APL_0096*APL_0096*Zinc transporter family protein ZIP1.592APL_0220*APL_0220*Putative lipoprotein1.583APL_1934*APL_1934*Hypothetical protein1.570APL_1574*APL_1574*Hypothetical protein1.543APL_0036*APL_0036*Hypothetical protein1.533APL_0222*APL_0222*Putative lipoprotein1.518APL_1088*APL_1088*Hypothetical protein1.512APL_1207*APL_1207*Hypothetical protein1.510APL_0463*APL_0463*Predicted sortase and related acyltransferases1.448APL_1859*APL_1859*Probable NADH-dependent butanol dehydrogenase 11.448APL_1828*APL_1828*PilT protein-like protein1.447APL_0433*msrB*Methionine sulfoxide reductase B1.415APL_1189*APL_1189*Hypothetical protein1.393APL_0090*APL_0090*Hypothetical protein1.360APL_1709*APL_1709*Hypothetical protein−1.307APL_0357*APL_0357*Hypothetical protein−1.328APL_1380*APL_1380*Hypothetical protein−1.394APL_1729*APL_1729*Hypothetical protein−1.401APL_1062*APL_1062*Hypothetical protein−1.468APL_0179*APL_0179*Hypothetical protein−1.481APL_0940*APL_0940*Hypothetical protein−1.482APL_1273*APL_1273*Putative fimbrial biogenesis and twitching motility protein PilF-like protein−1.488APL_1131*APL_1131*Hypothetical protein−1.540APL_0583*APL_0583*Hypothetical protein−1.585APL_1096*APL_1096*Hypothetical protein (59% ID dispersine B)−1.594APL_0936*APL_0936*Hypothetical protein−1.616APL_1115*APL_1115*Hypothetical protein−1.639APL_0811*APL_0811*Hypothetical protein−1.682APL_1898*ap2029*Hypothetical protein−1.798APL_1654*gidB*Methyltransferase GidB−1.816APL_0340*APL_0340*Hypothetical protein−1.893APL_1381*APL_1381*Hypothetical protein−1.926APL_0053*typA*GTP-binding protein−2.043APL_1681*APL_1681*Hypothetical protein−2.233

3.4.. Effect of DspB on biofilm formation {#S17}
-----------------------------------------

Enzymatic treatment with DspB of biofilms of *A*. *pleuropneumoniae* strains S4074 and L20 grown for 6 or 24 h almost completely dispersed them (*p* \< 0.05) confirming the presence of PGA in the biofilm matrix.

3.5.. Effect of zinc on biofilm formation {#S18}
-----------------------------------------

Chemical analysis showed differences in some divalent cations concentration between BHI-A (Fe \< 0.10 ppm, Zn 2.03 ppm) and BHI-B (Fe 0.10 ppm, Zn 1.75 ppm) while no differences were observed for others (Ca, Cu, Mg, Mn). We therefore hypothesized that the difference in biofilm formation observed after growth in BHI-B compared to BHI-A might be due to cations concentration. Since the concentration of zinc was found to be higher in BHI-A (no or slight biofilm) we tested a possible inhibitory effect of this cation on biofilm formation. The addition of ZnCl~2~ to BHI-B inhibited, in a dose-dependent manner, the formation of biofilms by *A*. *pleuropneumoniae* strains S4074 and L20 ([Fig. 5](#F5){ref-type="fig"}). A complete inhibition (*p* \< 0.01) was observed when 100 μg/mL of ZnCl~2~ was added to BHI-B, a concentration which did not affect growth after 24 h (data not shown). A similar inhibition was also observed with the addition of ZnSO~4~, ZnO, and Zn~3~(PO~4~)~2~ but not with MgCl~2~ or CaCl~2~ thus confirming that the inhibition was due to the addition of zinc. Biofilm formation in *A*. *actinomycetemcomitans* was also inhibited by zinc (data not shown). Interestingly, genes potentially involved in zinc transport (*znuA* and APL_0096) were up-regulated after growth in BHI-B ([Tab. II](#T2){ref-type="table"}).Figure 5.Effect of the addition of ZnCl~2~ on biofilm formation by *A*. *pleuropneumoniae* serotype 1 strain S4074 (App1) and serotype 5b strain L20 (App5b) grown for 6 h.

4.. DISCUSSION {#S19}
==============

Biofilm formation is an important virulence trait of many bacterial pathogens including *A*. *pleuropneumoniae*. It has been previously reported that only 2 of the 15 *A*. *pleuropneumoniae* reference strains, representing serotypes 5b and 11, were able to form a biofilm in vitro \[[@R21]\]. We observed however an increased stickiness of colonies when strain *A*. *pleuropneumoniae* S4074 was grown on plates made of BHI from one of two different suppliers. In addition, Li et al. \[[@R24]\] recently observed slight biomass of biofilm when the *A*. *pleuropneumoniae* serotype 1 reference strain S4074 was grown in serum-free TSB and that an enhanced biofilm formation was observed in *luxS* \[[@R24]\] and *hns* \[[@R8]\] mutants of *A*. *pleuropneumoniae* S4074. These observations brought us to re-evaluate biofilm formation by strain *A*. *pleuropneumoniae* S4074 under different growth conditions using a standard microtiter plate and crystal violet staining protocol. Our data indicate that strain S4074 has the ability to form a pronounced biofilm when grown in the appropriate conditions, and that the biofilm was sensitive to DspB treatment and can be inhibited by zinc. Transition from a biofilm-positive to a biofilm-negative phenotype is not irreversible in contrast to what was reported by Kaplan and Mulks \[[@R21]\] under different conditions.

Transcript profiling experiments using DNA microarrays indicated that overall, 232 genes were significantly differentially expressed during growth in BHI-B. Genes such as *tadC*, *tadD*, genes with homology to autotransporter adhesins as well as genes *pgaABC* involved in PGA biosynthesis were up-regulated after growth in BHI-B. While we can hypothesize that these genes might be important for the formation of the biofilm itself, it is also interesting to note that many of the same genes (*tadB*, *rcpA*, gene APL_0443 with high homology to the Hsf autotransporter adhesin of *Haemophilus influenzae* as well as genes *pgaBC* involved in biofilm biosynthesis) were up-regulated, when the transcriptomic profile of *A*. *pleuropneumoniae* was determined after contact with porcine lung epithelial cells \[[@R1]\], thus emphasizing the possible importance of biofilm formation for the establishment of the infection.

Initial steps in biofilm development require the transcription, early on, of genes involved in reversible attachment and motility, before a subsequent switch towards the transcription of genes involved in the irreversible attachment of bacteria \[[@R35]\]. This second irreversible attachment might require the synthesis of adhesive organelles, such as the curli fibers (*csg* genes). Interestingly, gene APL_0220 is a putative lipoprotein of the CsgG family, responsible for the transport and assembly of curli fibers. The up-regulation of other genes possibly involved in adhesion processes (*tadC*, *tadD*, Hsf homolog APL_0443) might indicate that bacterial cells were entering or in the middle of this irreversible attachment phase. In *A*. *actinomycetemcomitans*, the Tad locus is essential for biofilm formation \[[@R32]\]. The fact that the transcription of a zinc-specific transporter (*znuA*) was increased, combined with the decrease in transcription of an hypothetical Zn-dependant protease (APL_1898) and lower concentration of this metal in BHI-B lead us to believe that Zn restriction might be a signal leading to increase biofilm formation.

It is tempting to speculate that growth in BHI-B affected the expression of regulators which in turn affected PGA expression and biofilm formation. Indeed, it has been recently shown that an enhanced biofilm formation was observed in a *hns* mutant of *A*. *pleuropneumoniae* strain S4074 \[[@R8]\] and that over-expression of RpoE in a *rseA* mutant is sufficient to alleviate repression of biofilm formation by H-NS[1](#FN2){ref-type="fn"}. However, other genes have been shown to affect biofilm formation in *A*. *pleuropneumoniae*. An enhanced biofilm formation was observed in a quorum sensing (*luxS*) mutant \[[@R24]\] while a mutant in the ArcAB two-component system facilitating metabolic adaptation to anaerobicity (*arcA*) \[[@R5]\] and an autotransporter serine protease (AasP) mutant were deficient in biofilm formation \[[@R31]\]. It is interesting to note that many genes involved in branched-chain amino acid biosynthesis (*ilv* genes) were up-regulated after growth in BHI-B. Limitation of branched-chain amino acids was shown to be a cue for expression of a subset of in vivo induced genes in *A*. *pleuropneumoniae*, including not only genes involved in the biosynthesis of branched-chain amino acids, but also other genes that are induced during infection of the natural host \[[@R34]\].

Our data indicate that many strains of *A*. *pleuropneumoniae* have the ability to form biofilms under appropriate growth conditions. This is an important observation considering that *A*. *pleuropneumoniae* biofilm cells exhibit increased resistance to antibiotics compared to planktonic cells \[[@R17]\] and may also exhibit increased resistance to biocides \[[@R12]\]. Biofilms are often associated with chronic infections but the fact that *A*. *pleuropneumoniae* can form an important biofilm after only 6 h of incubation suggests that biofilm formation might also play a role in acute infections.

We have undertaken the screen of a large library of mini-*Tn10* isogenic mutants of *A*. *pleuropneumoniae* S4074 in order to identify other genes that are involved in biofilm formation and/or regulation. A better understanding of biofilm formation in *A*. *pleuropneumoniae* might lead to the development of molecules or strategies to interfere with biofilm formation and prevent infection in pigs. In that respect, we made an important, and unexpected, observation that zinc could completely inhibit biofilm formation in *A*. *pleuropneumoniae* and *A*. *actinomycetemcomitans*, which also synthesizes PGA \[[@R20]\]. We do not know at this time how zinc interferes with PGA biosynthesis and biofilm formation but some glycosyltransferases have been shown to be inhibited by zinc \[[@R23]\]. Hypozincemia which occurs during infection and inflammation \[[@R26]\] might therefore favour biofilm formation by *A*. *pleuropneumoniae*. Knowing that PGA functions as a biofilm matrix polysaccharide in phylogenetically diverse bacterial species such as *Staphylococcus aureus*, *S*. *epidermidis*, and *Escherichia coli* \[[@R20]\], it would be worth investigating whether zinc can also interfere with PGA biosynthesis in these other bacterial pathogens.
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